EFSD/Novo Nordisk Foundation Precision Diabetes Medicine Award

The EFSD/Novo Nordisk Foundation Precision Diabetes Medicine Award is an annual recognition established to support research in the field of precision diabetes medicine. The award is a joint initiative between the European Foundation for the Study of Diabetes (EFSD) and the Novo Nordisk Foundation. Its purpose is to advance the understanding and application of personalised approaches to diabetes care.

Objective and purpose

The award seeks to facilitate the implementation of innovative and individualized treatment strategies and to promote advancements in precision medicine for diabetes care.

Award structure

The program provides three awards annually:

• Winner: Receives DKK 2 million to support research over a three-year period.
• Two Runners-up: Each receives DKK 0.5 million for research funding over three years

Selection process

Applications are evaluated by an independent ad hoc committee organized by the EFSD. The committee assesses submissions based on criteria such as scientific quality, innovation, and potential impact on diabetes care. Funding for the award is provided by the Novo Nordisk Foundation.

Review criteria

The evaluation of applications is based on the following criteria:

• Significance: The relevance of the study to the program and its potential to advance scientific knowledge
• Approach: The development, integration, and appropriateness of the conceptual framework, design, methods, and analyses.
• Innovation: The degree to which the project incorporates novel concepts, approaches, or methods.
• Investigator: The qualifications and suitability of the investigator to execute the project.
• Environment: The contribution of the scientific environment to the project's success.
• Budget and Feasibility: The appropriateness of the requested budget and timeline for completing the project.
• Contribution to a Larger Research Project: If the application is part of a larger project, the clarity of its contribution to the overall objectives is assessed.

Previous recipients

Source:

Year	Recipient	Associated institution
2021	Thomas Pieber	Medical University of Graz – Austria
2021	Caroline Bonner	Institut Pasteur de Lille – Franc
2021	Charlotte Ling	Lund University – Malmo, Sweden
2022	Jørgen Wojtaszewski	University of Copenhagen – Denmark
2022	Haifa Maalmi	German Diabetes Center – Düsseldorf, Germany
2022	Angus Jones	University of Exeter – England
2023	Cyrielle Caussy	Lyon University Hospital Center – France
2023	Eran Elinav	Weizmann Institute of Science – Rehovot, Israel
2023	Shivani Misra	Imperial College – London, England